Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mohammed M Keshawy"'
Publikováno v:
Archives of Medical Science, Vol 19, Iss 5, Pp 1508-1519 (2023)
Introduction Obesity is one of the most burdensome health problems and is closely linked to leptin resistance. The study examined whether an alternate-day high-fat diet (ADF) and/or GLP-1 agonist (exenatide) modulate brain leptin resistance caused by
Externí odkaz:
https://doaj.org/article/7a5dffc8700b43888d45d32e3d908010
Autor:
Gehad M. Elnagar, Mohamed M. Elseweidy, Nesreen M.I.M. Elkomy, Mohammed M. Keshawy, Ola M. Fathy, Mohammed S. Sobh, Yasmin K. Mahmoud
Publikováno v:
Journal of Functional Foods, Vol 97, Iss , Pp 105250- (2022)
Hyperlipidemia represents a major risk factor for cardiovascular and renal diseases. This study aimed to demonstrate the possible ameliorating effects of policosanol (PC) on renal inflammation and pyroptosis. Eighteen male New Zealand rabbits were ra
Externí odkaz:
https://doaj.org/article/9cfa9c010d894a548e9bbe26d243d4bd
Publikováno v:
Archives of Medical Science, Vol 17, Iss 6, Pp 1783-1796 (2021)
Introduction Ischemic preconditioning (Ipre) provides protection against renal ischemia-reperfusion (I/R) injury with its associated remote organ damage. This study examined the enhancing protective effect of Ipre with levosimendan or cilostazol in I
Externí odkaz:
https://doaj.org/article/0df7e20c51294f7296e0e5c68d7ccff0
Publikováno v:
Suez Canal University Medical Journal. 24:104-108
Background:The presence of insulin resistance (IR) and compensatory hyper-insulinemia is strongly associated with chronic kidney disease (CKD) stages and constellates with other abnormalities such as obesity, hypertension, and dyslipidemia. CKD is as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee6045e09d120b1f0e75d97296a88906
https://doi.org/10.21608/scumj.2021.192013
https://doi.org/10.21608/scumj.2021.192013
Publikováno v:
Suez Canal University Medical Journal. 24:128-134
Background: Chronic kidney disease (CKD) is associated with significant morbidity and mortality. Many factors including inflammation, oxidative stress, and vitamin D deficiency contribute to insulin resistance (IR). Vitamin D requires attention becau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff90b07493133b5ac37cd45879de77c7
https://doi.org/10.21608/scumj.2021.192460
https://doi.org/10.21608/scumj.2021.192460
Publikováno v:
Molecular Biology Reports. 48:6457-6470
Diabetic nephropathy (DN) is a consequence of diabetes mellitus (DM) and is associated with early changes in renal angiotensin II (ANG II). These changes were evaluated using ANG II blocker valsartan early from week two of diabetes (experiment I, ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::306c2e92fd6c0ccc5c9d245e132a54be
https://doi.org/10.1007/s11033-021-06647-9
https://doi.org/10.1007/s11033-021-06647-9
Publikováno v:
Suez Canal University Medical Journal. 22:122-128
Background: Lupus nephritis accounts for significant morbidity and mortality in patients with systemic lupus erythematosus (SLE). Many biomarkers for renal involvement in SLE have been suggested in Egyptian patients; one of them is Monocyte chemoattr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da73e32a76a42640c9855c2b21b9cdfd
https://doi.org/10.21608/scumj.2019.94976
https://doi.org/10.21608/scumj.2019.94976
Diabetic nephropathy (DN) is a consequence of diabetes mellitus (DM). DM is associated temporal changes in renal angiotensin II (ANG II) release and multiple mediators leading to DN. These changes were evaluated using early ANG II blocker valsartan a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bdc14d6b2e68723636648b8f2688e5e
https://doi.org/10.21203/rs.3.rs-256235/v1
https://doi.org/10.21203/rs.3.rs-256235/v1
Publikováno v:
Molecular biology reports. 48(9)
Diabetic nephropathy (DN) is a consequence of diabetes mellitus (DM) and is associated with early changes in renal angiotensin II (ANG II). These changes were evaluated using ANG II blocker valsartan early from week two of diabetes (experiment I, ren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62fad6229d0a07541ed7c7255e84fb89
https://pubmed.ncbi.nlm.nih.gov/34431038
https://pubmed.ncbi.nlm.nih.gov/34431038
Autor:
Mohammed M Keshawy, Maha M Al-Abbassy
Publikováno v:
Suez Canal University Medical Journal. 21:88-98
Background: Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disease presenting clinically by abdominal pain with alteration of bowel habits. Although IBS has uncertain etiology, chronic gut inflammation due to persistent expos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c952ed95d0b45cf2d2e8f1d86cd647b
https://doi.org/10.21608/scumj.2018.43541
https://doi.org/10.21608/scumj.2018.43541